Blood Coagulation Markers – Overview & Values

What Are Blood Coagulation Markers?

Blood coagulation markers are specific laboratory parameters measured in the blood to assess the function of the hemostatic system – the body's blood-clotting mechanism. They indicate whether blood clots normally, whether there is an increased tendency to bleed, or whether a person is at elevated risk for thrombosis (blood clots). These markers play a central role in the diagnosis, treatment monitoring, and risk assessment of numerous medical conditions.

Physiological Basis of Blood Coagulation

Blood coagulation is a complex, multi-step process activated after a vascular injury. It involves two main pathways:

• Primary hemostasis: Platelets adhere to the injured vessel wall and form a temporary plug.
• Secondary hemostasis (plasma coagulation): A cascade of clotting factors is activated, ultimately leading to the formation of fibrin, which stabilizes the platelet plug.

At the same time, the fibrinolytic system ensures that blood clots are dissolved after wound healing. An imbalance in this system can lead to bleeding disorders or an increased tendency toward thrombosis.

Key Blood Coagulation Markers at a Glance

Prothrombin Time (PT) and INR

The prothrombin time (PT) measures the time it takes for blood to clot via the extrinsic coagulation pathway. It is commonly used to monitor therapy with vitamin K antagonists (e.g., warfarin). The internationally standardized value is expressed as the INR (International Normalized Ratio).

Activated Partial Thromboplastin Time (aPTT)

The aPTT tests the intrinsic coagulation pathway and is used, among other things, to monitor heparin therapy. Prolonged aPTT values can indicate a deficiency of certain clotting factors or the presence of lupus anticoagulants.

Fibrinogen

Fibrinogen is a soluble plasma protein that is converted by thrombin into insoluble fibrin, forming the scaffold of a blood clot. Low fibrinogen levels may indicate consumptive coagulopathy (e.g., DIC – disseminated intravascular coagulation), while elevated levels are considered a cardiovascular risk factor.

D-Dimers

D-dimers are degradation products of cross-linked fibrin that are released when a blood clot is dissolved. Elevated D-dimer levels are an important indicator of active clotting processes and are particularly used to rule out deep vein thrombosis (DVT) or pulmonary embolism.

Thrombin Time (TT)

The thrombin time measures the conversion of fibrinogen to fibrin after the addition of thrombin. It is prolonged in cases of fibrinogen disorders or when heparin is present in the blood.

Antithrombin (AT)

Antithrombin is a natural inhibitor of coagulation. A deficiency in antithrombin significantly increases the risk of thrombosis and can be congenital or acquired (e.g., in liver disease or nephrotic syndrome).

Protein C and Protein S

Protein C and Protein S are vitamin K-dependent anticoagulants. Deficiencies in either lead to an increased tendency for thrombosis. Both parameters are measured during thrombophilia screening.

Factor V Leiden and Prothrombin Gene Mutation

These genetic alterations increase thrombosis risk and are investigated as part of molecular genetic thrombophilia workup. While not classic laboratory markers in the traditional sense, they are part of comprehensive coagulation diagnostics.

Platelet Count and Function

The number of platelets and their function (e.g., measured with the PFA-100 test) are essential for assessing primary hemostasis. Thrombocytopenia (too few platelets) increases the risk of bleeding.

Clinical Significance and Applications

Blood coagulation markers are used in many clinical situations:

• Preoperative assessment: Coagulation parameters are routinely measured before surgery to evaluate bleeding risk.
• Thromboembolic diagnosis: D-dimers and other markers help in the workup of suspected DVT or pulmonary embolism.
• Therapy monitoring: Regular monitoring of coagulation parameters is necessary when treating with anticoagulants such as heparin or vitamin K antagonists.
• Thrombophilia workup: Comprehensive coagulation testing is performed in patients with recurrent thromboses or a family history of clotting disorders.
• Liver disease: Since many clotting factors are produced in the liver, coagulation markers also reflect liver function.
• Intensive care: Monitoring coagulation is vital in critically ill patients, for example in sepsis or DIC.

Reference Values and Interpretation

Reference ranges for individual coagulation markers may vary slightly between laboratories and methods. Typical reference values include:

• PT / INR: 70–130% (PT activity); INR 0.8–1.2 (therapeutic range during anticoagulation: 2.0–3.5 depending on indication)
• aPTT: 25–38 seconds
• Fibrinogen: 2.0–4.0 g/l
• D-dimers: below 0.5 mg/l (age-adjusted cutoffs may apply)
• Platelets: 150,000–400,000 per microliter
• Antithrombin: 80–120%

All values should always be interpreted in clinical context and in consultation with a qualified healthcare professional.

References

1. Levi M, Scully M. How I treat disseminated intravascular coagulation. Blood. 2018;131(8):845-854. PubMed PMID: 29255070.
2. Tripodi A, Mannucci PM. The coagulopathy of chronic liver disease. New England Journal of Medicine. 2011;365(2):147-156.
3. Konstantinides SV et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism. European Heart Journal. 2020;41(4):543-603.